These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 7197973)

  • 1. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of amezinium in man.
    Wilsmann K; Neugebauer G; Kessel R; Lang E
    Arzneimittelforschung; 1981; 31(9a):1638-46. PubMed ID: 7197978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action.
    Traut M; Brode E; Hoffmann HD
    Arzneimittelforschung; 1981; 31(9a):1566-74. PubMed ID: 7197971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine.
    Wilsmann K; Neugebauer G; Kessel R; Lang E
    Arzneimittelforschung; 1981; 31(9a):1647-52. PubMed ID: 7197979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fate of amezinium in humans and animals.
    Traut M; Kummer H; Brode E
    Arzneimittelforschung; 1981; 31(9a):1616-22. PubMed ID: 7197976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T
    Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on central nervous and sensory systems and other functions.
    Yamamoto S; Takemori E; Hasegawa Y; Nakao K; Inukai T; Nomura M; Morino K; Tsuchiyama M; Hasegawa K; Ikeda H
    Arzneimittelforschung; 1991 Jun; 41(6):602-7. PubMed ID: 1930347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.
    Kato M; Nishida A; Aga Y; Kita J; Kudo Y; Narita H; Endo T
    Arzneimittelforschung; 1997 Oct; 47(10):1116-24. PubMed ID: 9368705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
    Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
    Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ritodrine hydrochloride on motor nervous system and central nervous system].
    Ikeda S; Tsukamoto T
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):311-26. PubMed ID: 6500405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.